![Veronica Byfield Sköld](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Veronica Byfield Sköld
Director Ejecutivo en BioLamina AB .
Origen de la red de primer grado Veronica Byfield Sköld.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
BioLamina AB
![]() BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.
8
| Holding Company | Biotechnology | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Veronica Byfield Sköld a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
BioPhausia AB
![]() BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Chief Executive Officer | |
GENOVIS AB | Medical Specialties | Director/Board Member | |
BURE EQUITY AB | Financial Conglomerates | Director of Finance/CFO Chief Investment Officer | |
MEDIVIR AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
ALLGON AB (PUBL) | Telecommunications Equipment | Chairman | |
GE Healthcare AS
![]() GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Medical Specialties | Chief Executive Officer | |
ORASOLV AB | Medical/Nursing Services | Director of Finance/CFO | |
Carmeda AB
![]() Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
The University of Chicago | College/University | Masters Business Admin | |
New York University | College/University | Undergraduate Degree | |
Royal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
Bure Equity (Private Equity)
![]() Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Investment Managers | Director of Finance/CFO | |
Atlas Antibodies AB
![]() Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member | |
Celemiab Group AB
![]() Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Celemiab Group AB provides consultancy and training services. The firm offers organizational learning. It helps businesses improves corporate merger, product launch, and new corporate strategy results through business simulations and training solutions. The company was founded by Klas Mellander, Eva Brita Margareta Barchan, and Krister Nathanaelson in 1985 and is headquartered in Malmo, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Scope Capital Advisory AB
![]() Scope Capital Advisory AB Investment ManagersFinance Scope Capital Advisory AB (Scope Capital) is a venture capital firm founded in 2000 by Fredrik Eugen Oweson, Andreas Markus Alexander Ossmark and Mikael Elias Kamras. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
Faculty of Engineering, Lund University | College/University | Graduate Degree | |
VINNOVA AB
![]() VINNOVA AB Financial ConglomeratesFinance VINNOVA AB provides funding services and financial assistance. It promotes collaborations between companies, universities, research institutes and the public sector. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
AROCELL AB | Medical Specialties | Director/Board Member | |
IMED AB
![]() IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Drugstore Chains | Chief Executive Officer | |
Dipylon Medical AB
![]() Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
BIOARCTIC AB | Pharmaceuticals: Major | Director/Board Member | |
SwedenBIO Service AB
![]() SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman | |
GE UK Group
![]() GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous | Corporate Officer/Principal | |
GE Healthcare AB
![]() GE Healthcare AB Pharmaceuticals: MajorHealth Technology GE Healthcare AB wholesales and distributes pharmaceutical products. It promotes contrast agents for X-rays, magnetic resonance imaging, ultrasound and radiopharmaceuticals, use to predict and diagnose early-stage diseases. The company was founded on October 21, 1983 and is headquartered in Danderyd, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
American Chamber of Commerce in Sweden
![]() American Chamber of Commerce in Sweden Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Sweden was founded in 1992 and operates as a chamber of commerce. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
University of California | College/University | Graduate Degree | |
Global Life Sciences Solutions USA LLC
![]() Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a company that manufactures therapeutics. The company is based in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GE Healthcare Sverige AB
![]() GE Healthcare Sverige AB Medical DistributorsDistribution Services Part of General Electric Co., GE Healthcare Sverige AB is a company that develops, sells, and rents medical equipment. The company is based in Stockholm, Sweden. The Swedish company also provides consulting and training services in the healthcare sector. | Medical Distributors | Director/Board Member | |
International General Electric AB | Director/Board Member | ||
Stockholm School of Economics Ifl | College/University | Director of Finance/CFO | |
ABZENA PLC | Biotechnology | Director/Board Member | |
Science for Life Laboratory
![]() Science for Life Laboratory Miscellaneous Commercial ServicesCommercial Services Science for Life Laboratory, also known as scilifelab, is a national resource in Sweden that provides unique technologies and expertise to life scientists. The private company is based in Solna, Sweden. The Swedish company is closely connected to a community of researchers in various fields such as biomedicine, ecology, and evolution. | Miscellaneous Commercial Services | Director/Board Member | |
Atle Investment Management AB | Director/Board Member | ||
Bure Growth AB
![]() Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Celemi International AB | Director/Board Member | ||
Bioprocess Innovation Center
![]() Bioprocess Innovation Center BiotechnologyHealth Technology Bioprocess Innovation Center develops biopharmaceutical products. The CEO of the Swedish company is Charlotta Ljungqvist. | Biotechnology | Chief Executive Officer | |
SEB Group (Sweden) | Corporate Officer/Principal | ||
Glycovisc BioTech AB | Director/Board Member | ||
Testa Center | Chief Executive Officer | ||
Skanditek AB | Director/Board Member | ||
Cytiva Testa Center AB
![]() Cytiva Testa Center AB Miscellaneous Commercial ServicesCommercial Services Cytiva Testa Center AB is a Swedish company that provides an open and friendly testbed for biological production. The private company is based in Uppsala, Sweden. The company offers hands-on training, digital applications, and access to bioprocessing labs, equipment, and expertise to help ensure the success of your project. The company was founded in 2018, and the CEO is Jesper Hedberg. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sse Executive Education | Director of Finance/CFO | ||
NorthX Biologics Matfors AB
![]() NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
YUBICO AB | Electronics Distributors | Director of Finance/CFO |
Estadísticas
Internacional
Suecia | 41 |
Estados Unidos | 7 |
Noruega | 3 |
Reino Unido | 3 |
Sectorial
Health Technology | 16 |
Finance | 7 |
Commercial Services | 7 |
Consumer Services | 7 |
Distribution Services | 4 |
Operativa
Director/Board Member | 62 |
Chief Executive Officer | 14 |
Chairman | 14 |
Independent Dir/Board Member | 11 |
Corporate Officer/Principal | 9 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Veronica Byfield Sköld
- Conexiones Empresas